Gelteq Limited Ordinary Shares (GELS) is a publicly traded Healthcare sector company. As of September 3, 2026, GELS trades at $0.85 with a market cap of $5.70M and a P/E ratio of 0.00. GELS moved +19.14% today. Year to date, GELS is -16.44%; over the trailing twelve months it is -37.50%. Its 52-week range spans $0.39 to $4.11. Rallies surfaces GELS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for GELS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.85 |
| Market Cap | $5.70M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.11 |
| 52-Week Low | $0.39 |
| Volume | 62.87M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
GELS analyst coverage data. Average price target: $0.00.